podcast interviews Articles and Reports
Our podcast interviews feature the best and brightest executives and researchers in artificial intelligence today, and each episode highlights current and near-term AI use-cases of value for business leaders. Explore our full list of AI podcast episodes below:
I love me a good book, don't get me wrong - but I still think that the best way to learn startup marketing is by modeling successful people and successful businesses. Rand Fishkin is CEO and found of MOZ (formerly "seoMOZ"), and he's one of a number of enthusiastic startup founders who seems to "let it all out" in interviews and presentations about growth. In this presentation for "Hackers and Founders," Rand dives into the dynamic of "interruption marketing" versus "inbound marketing."
If you suspected that bioengineering is the new frontier of human endeavor, the experts agree. Genomics - with its proliferation of metaphors - scientists as pioneers and bioengineering as the home of innovation and rugged individualism - is the new Wild West. Consumer genomics, made possible by the plummeting costs of DNA testing and its growing popularity via the internet, is already a reality. Its current and future value in medical diagnostics, as well as a timetable within which it can become widely available as a healthcare tool for the general population, are the topic of much debate.
Have you ever wondered why some startups get loads of hype immediately after their launch and others don't? Is it down to an auspicious alignment of the planets or just sheer luck? The answer is neither; it's all down to virality. And according to leading expert in internet virality, Emerson Spartz, you have to create your own.
Dr. Charles Sidman started off getting his Masters and PhD in Immunology and Harvard, and dove into research and professorship. It was thinking about the applications and possibilities of his research that brought him to the world of business and investments. "There's a part of grant writing where you have to mention significant - why your project matters in the world... that's what got involve with consulting activities, application and commercialization." This yearning to step outside the lab has resulted in hundreds of speeches, presentations and consulting jobs with companies and organizations around the world, eventually landing Charles in position as a Managing Partner of ECS Capital Partners, LLC.
Tute Genomics is part of a grand shift towards the leveraging of genetic information towards better health and better treatments. One of the "holy grails" of this transition from one to the other is the advent of